This is a contract page; to update your booth information or to see exhibitor tasks, return to the Exhibitor Hub.

The ACR Convergence 2025 Floor Plan may be accessed using "exhibitor floorplan" from the dropdown menu above.

The booth application form may be accessed from the dropdown menue above (log-in required).

To access exhibitor suite sales, select the Sponsorship Gallery from the dropdown menu above.

Selecting My Account will permit you to view your current orders, invoices, or to make payment.

Exhibitor Hub will take you to Exhibitor Resource Center where you can access your to-do list and other show-specific items.

For assistance with accessing these pages (password or auth codes), please contact exhibits@rheumatology.org.

CRISPR Therapeutics

South Boston, MA
United States
https://crisprtx.com/

Booth: 1417

CASGEVY? (exagamglogene autotemcel), a CRISPR/Cas9 gene-edited therapy arising out of our collaboration with Vertex Pharmaceuticals Incorporated, is approved in some countries for certain eligible patients with sickle cell disease or transfusion-dependent beta thalassemia.

CRISPR Therapeutics

Send Mail